People | April 29, 2026
NADMED Limited appoints James Lee as CEO to drive global expansion
Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation
Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation
The deal signals a clear push to expand access to care in underserved regions
Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Analysts expect modest revenue growth but pressure on profitability in the March quarter
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
Subscribe To Our Newsletter & Stay Updated
